Mark Parta

1.4k total citations
36 papers, 779 citations indexed

About

Mark Parta is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Mark Parta has authored 36 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Mark Parta's work include Immunodeficiency and Autoimmune Disorders (10 papers), Antifungal resistance and susceptibility (9 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Mark Parta is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (10 papers), Antifungal resistance and susceptibility (9 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Mark Parta collaborates with scholars based in United States, Canada and Mali. Mark Parta's co-authors include Steven M. Holland, Dennis D. Hickstein, Jennifer Cuellar‐Rodríguez, Christa S. Zerbe, Riri Shibata, Georgina Miller, Kyung J. Kwon‐Chung, Torgny N. Fredrickson, Frank Maldarelli and Tetsuro Matano and has published in prestigious journals such as Blood, CHEST Journal and Journal of Clinical Microbiology.

In The Last Decade

Mark Parta

34 papers receiving 771 citations

Peers

Countries citing papers authored by Mark Parta

Since Specialization

Citations

This map shows the geographic impact of Mark Parta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Parta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Parta more than expected).

Fields of papers citing papers by Mark Parta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Parta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Parta. The network helps show where Mark Parta may publish in the future.

Co-authorship network of co-authors of Mark Parta

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Parta. A scholar is included among the top collaborators of Mark Parta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Parta. Mark Parta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy 2024 ·Frontiers in Immunology ·(unknown), Pamela Stratton, Dominique C. Pichard, Beatriz E. Marciano, Edward W. Cowen, Alison A. McBride, Koenraad Van Doorslaer, Melissa A. Merideth, Noemi Salmeri, Marybeth S. Hughes, Theo Heller, Mark Parta, Dennis D. Hickstein, Heidi H. Kong, Steven M. Holland, Christa S. Zerbe	1
2	Outcomes in hematopoetic cell transplantation in the setting of mold infections in patients with chronic granulomatous disease 2024 ·Bone Marrow Transplantation ·(unknown), Mark Parta, Jennifer Cuellar‐Rodríguez, Juan Gea‐Banacloche, Corin Kelly, Stefania Pittaluga, Christa S. Zerbe, Steven M. Holland, Harry L. Malech, Elizabeth M. Kang	3
3	Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease 2022 ·Transplant Infectious Disease ·Mark Parta, Jennifer Cuellar‐Rodríguez, Juan Gea‐Banacloche, Jing Qin, Corin Kelly, Christa S. Zerbe, Steven M. Holland, Harry L. Malech, Elizabeth M. Kang	1
4	Pulmonary Manifestations of GATA2 Deficiency 2021 ·CHEST Journal ·Beatriz E. Marciano, Kenneth N. Olivier, Les Folio, Christa S. Zerbe, Amy P. Hsu, Alexandra F. Freeman, Armando Filie, Michael A. Spinner, Lauren Sanchez, (unknown), Mark Parta, Jennifer Cuellar‐Rodríguez, Dennis D. Hickstein, Steven M. Holland	29
5	Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease 2020 ·Journal of Clinical Immunology ·Mark Parta, Dianne Hilligoss, Corin Kelly, Nana Kwatemaa, Narda Theobald, Christa S. Zerbe, Steven M. Holland, Harry L. Malech, Elizabeth M. Kang	11
6	Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen 2018 ·Biology of Blood and Marrow Transplantation ·Mark Parta, Nirali N. Shah, Kristin Baird, Hind Rafei, Katherine R. Calvo, Thomas E. Hughes, Kristen Cole, (unknown), (unknown), Jennifer Cuellar‐Rodríguez, Christa S. Zerbe, Steven M. Holland, Dennis D. Hickstein	55
7	Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection 2017 ·Leukemia Research Reports ·(unknown), Sawa Ito, Jeffrey R. Strich, Maura Manion, Celina Montemayor, Hao‐Wei Wang, Karolyn A. Oetjen, (unknown), Austin John Barrett, Mark Parta, Juan Gea‐Banacloche, Steven M. Holland, Christopher S. Hourigan, Catherine Lai	7
8	Monozygotic twins with GATA2 deficiency: same haploidentical-related donor, different severity of GvHD 2017 ·Bone Marrow Transplantation ·Nirali N. Shah, Mark Parta, Kristin Baird, Hind Rafei, Kristin Cole, Steven M. Holland, Dennis D. Hickstein	4
9	Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial 2017 ·Journal of Clinical Immunology ·Mark Parta, Corin Kelly, Nana Kwatemaa, Narda Theobald, (unknown), Jing Qin, Douglas B. Kuhns, Christa S. Zerbe, Steven M. Holland, Harry L. Malech, Elizabeth M. Kang	33
10	Resolution of Multifocal Epstein-Barr Virus-Related Smooth Muscle Tumor in a Patient with GATA2 Deficiency Following Hematopoietic Stem Cell Transplantation 2016 ·Journal of Clinical Immunology ·Mark Parta, Jennifer Cuellar‐Rodríguez, Alexandra F. Freeman, Juan Gea‐Banacloche, Steven M. Holland, Dennis D. Hickstein	14
11	Multidrug Resistant Pseudomonas aeruginosa Causing Prosthetic Valve Endocarditis: A Genetic-Based Chronicle of Evolving Antibiotic Resistance 2016 ·Open Forum Infectious Diseases ·Tatiana Domitrovic, Andrea M. Hujer, Federico Pérez, Steven H. Marshall, Kristine M. Hujer, Laila Woc-Colburn, Mark Parta, Robert A. Bonomo	21
12	Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Chronic Granulomatous Disease (CGD) Patients 2016 ·Biology of Blood and Marrow Transplantation ·Elizabeth M. Kang, Mark Parta, Dianne Hilligoss, Martha Marquesen, Corin Kelly, (unknown), Harry L. Malech	1
13	Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report 2015 ·Journal of Clinical Immunology ·Mark Parta, Dianne Hilligoss, Corin Kelly, Nana Kwatemaa, Narda Theobald, Harry L. Malech, Elizabeth M. Kang	26
14	Matched Related and Unrelated Donor Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency 2015 ·Biology of Blood and Marrow Transplantation ·Jennifer Cuellar‐Rodríguez, Alexandra F. Freeman, Jennifer Grossman, Helen C. Su, Mark Parta, H. Moses Murdock, Nirali N. Shah, Catherine M. Bollard, Heidi H. Kong, Niki M. Moutsopoulos, Kelly D. Stone, Juan Gea‐Banacloche, Steven M. Holland, Dennis D. Hickstein	31
15	Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency 2014 ·Biology of Blood and Marrow Transplantation ·Jennifer Grossman, Jennifer Cuellar‐Rodríguez, Juan Gea‐Banacloche, Christa S. Zerbe, Katherine R. Calvo, Thomas E. Hughes, Fran Hakim, Kristen Cole, Mark Parta, Alexandra F. Freeman, Steven M. Holland, Dennis D. Hickstein	64
16	Impact of an Assay That Enables Rapid Determination of Staphylococcus Species and Their Drug Susceptibility on the Treatment of Patients with Positive Blood Culture Results 2010 ·Infection Control and Hospital Epidemiology ·Mark Parta, (unknown), (unknown), (unknown), Charles E. Stager, Daniel M. Musher	13
17	Impact of an Assay That Enables Rapid Determination of Staphylococcus Species and Their Drug Susceptibility on the Treatment of Patients with Positive Blood Culture Results 2010 ·Infection Control and Hospital Epidemiology ·Mark Parta, (unknown), (unknown), (unknown), Charles E. Stager, Daniel M. Musher	68
18	Identification and Characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx Recombinant Subtypes in Mali, West Africa 2009 ·AIDS Research and Human Retroviruses ·Hiromi Imamichi, Ousmane Koita, Djénéba Dabitao, (unknown), (unknown), (unknown), Robin Dewar, (unknown), (unknown), Mark Parta, (unknown), Michael A. Polis, H. Clifford Lane, Anatole Tounkara	11
19	Retrospective surveillance of HIV prevalence in blood donors can help in the selection of the best social group for blood donation in Mali 2009 ·Transfusion Medicine ·A. Tounkara, (unknown), (unknown), (unknown), (unknown), Mark Parta	4
20	Infection and Pathogenicity of Chimeric Simian‐Human Immunodeficiency Viruses in Macaques: Determinants of High Virus Loads and CD4 Cell Killing 1997 ·The Journal of Infectious Diseases ·Riri Shibata, Frank Maldarelli, (unknown), Tetsuro Matano, Mark Parta, Georgina Miller, Torgny N. Fredrickson, María Ángeles Martín	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact